For research use only — not intended for human consumption. All content is educational.

Research

Studies

Summaries of key clinical trials and peer-reviewed research. Every article links directly to the source on PubMed.

Retatrutide Phase 3 results: 25% weight loss, no plateau at 2 years

Retatrutide

SURMOUNT-1: Tirzepatide Phase 3 trial — key findings

Tirzepatide

Retatrutide Phase 2b: 24% body weight reduction at 48 weeks

Retatrutide

Sikiric et al. — BPC-157 mechanism of action review

BPC-157

TB-500 and thymosin beta-4 — tissue repair evidence

TB-500

CJC-1295 pharmacokinetics — DAC vs no DAC study

CJC-1295

GHK-Cu — wound healing and collagen synthesis research

GHK-Cu